| NLS | Names Learning Test; Neu-Laxova syndrome; nonlinear least squares; normal lymphocyte supernatant |
|---|---|
| Tabs | tablets |
| CAP | camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab... |
| CAPP | Captopril Prevention Project [study] |
| NLS | Nuclear Localization Signal |
|---|---|
| NLS | Nuclear localization sequence |
| C | Captopril |
| CAP | Captopril |
| CP | Captopril |
| captopril | <chemical> An orally active inhibitor of angiotensin I-converting enzyme. It reduces elevated blood pressure by inhibiting the renin-angiotensin system and also inhibits pressure responses to exogenous angiotensin I. Pharmacological action: angiotensin-converting enzyme inhibitors, antihypertensive agents. Chemical name: L-Proline, 1-(3-mercapto-2-methyl-1-oxopropyl)-, (S)- (12 Dec 1998) |
|---|---|
| captopril renal scan | <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|